Summit X, LLC Cybin Inc. Transaction History

Summit X, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$0.3 - $0.56 $2,972 - $5,549	-9,909 Reduced 48.34%	10,591 $4,000
Q4 2022 Feb 02, 2023	BUY	$0.26 - $0.47 $1,302 - $2,354	5,009 Added 32.33%	20,500 $6,000
Q3 2022 Nov 01, 2022	SELL	$0.54 - $1.11 $2,704 - $5,559	-5,009 Reduced 24.43%	15,491 $7,000
Q4 2021 Jan 19, 2022	BUY	$1.13 - $2.31 $2,824 - $5,775	2,500 Added 13.89%	20,500 $25,000
Q3 2021 Oct 19, 2021	BUY	$1.83 - $3.18 $32,940 - $57,240	18,000 New	18,000 $39,000

109

243M

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $43.2M
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit X, LLC with notifications on news.